SAN FRANCISCO, Sept. 9 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals
(Nasdaq: VIAP), a biotechnology company focused on the development of
compounds for the treatment of cardiovascular disease, announced today that
James G. Stewart, senior vice president and chief financial officer, will
present a company update at Merriman Curhan Ford's 5th annual Investor Summit
on Monday, September 15, 2008 at 8 a.m. ET at the Mark Hopkins
InterContinental Hotel in San Francisco.
More information about the conference can be found at:
http://www.mcfco.com.
About VIA Pharmaceuticals, Inc.
VIA Pharmaceuticals, Inc. is a biotechnology company focused on the
development of compounds for the treatment of cardiovascular disease. VIA is
building a pipeline of small-molecule drugs that target a significant unmet
medical need: reducing inflammation in the blood vessel wall, which is an
underlying cause of atherosclerosis and its complications, including heart
attack and stroke. The company's lead drug candidate, VIA-2291, is in multiple
Phase 2 clinical studies in patients with cardiovascular disease. For more
information, visit: http://www.viapharmaceuticals.com.
About Merriman Curhan Ford
Merriman Curhan Ford (Nasdaq: MERR) is a financial services firm focused
on fast-growing companies and the institutions who invest in them. The company
offers high-quality investment banking, equity research, institutional
services, primary market research, asset management and corporate & venture
services, and specializes in four growth industry sectors: CleanTech,
Consumer/Internet/Media, Health Care and Tech/Telecom. For more information,
please go to http://www.mcfco.com.
SOURCE VIA Pharmaceuticals, Inc.